Skip to main content
Psych Congress 2023 Main banner
Back

Master Class
Breakout Session (CME)

The Psychiatry Clinicians’ Role in the Management of Parkinson Disease Psychosis With or Without Dementia

Saturday, September 9, 2023
10:30 AM – 11:45 AM CT
Location: Davidson C

Did you know that over half of patients with Parkinson disease will experience symptoms of psychosis and as many as 80% of patients with advanced PD experience hallucinations and delusions, regardless of the presence of age-associated dementia? Navigating the treatment of this complex disease can be difficult due to competing treatment paradigms with medications designed to help motor function negatively impacting emotions and behaviors. In this MasterClass session, expert faculty will critically evaluate the mechanism of action, clinical trial data, and real-world safety/efficacy data for current, emerging, and off-label therapies for PDP. Furthermore, they will discuss the implementation of multidisciplinary approaches to optimize care for patients with Parkinson's disease and PDP, emphasizing effective communication strategies and shared decision-making with patients and care partners. By the end of the session, participants will have gained valuable knowledge and skills to improve the care and outcomes of patients with PDP.

This session is supported by an educational grant from Acadia Pharmaceuticals Inc.

Learning Objectives:

  • Describe the prevalence, burden, and risk factors associated with PDP with and without dementia, including clinical features and triggers
  • Integrate validated assessment tools and clinical techniques into practice to identify psychosis early in patients with PD
  • Evaluate the mechanism of action and clinical trial and real-world safety/efficacy data for current, emerging, and off-label therapies for PDP
  • Implement multidisciplinary approaches to optimize care for patients with PD and PDP while engaging in effective communication strategies and shared decision making with patients and care partners